Compare Manhattan Associates Inc (MANH) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Manhattan Associates Inc vs Health Care Select Sector SPDR Fund — how do they compare? Manhattan Associates Inc trades at $204.89 (market cap $12.06B), while Health Care Select Sector SPDR Fund trades at $170.81 (market cap $43.48B). The key difference: Health Care Select Sector SPDR Fund is far larger — about 3.6× Manhattan Associates Inc's market cap, and Manhattan Associates Inc is more actively traded (376,150 versus 11,121,431). Which is the better fit depends on your goals — on Pluang, investors hold Manhattan Associates Inc for 12 Days and Health Care Select Sector SPDR Fund for 100 Days on average.
| MANH | XLV | |
|---|---|---|
Market Cap | $12.06B | $43.48B |
Volume | 376,150 | 11,121,431 |
Sector | Technology | — |
52-Week High | $223.76 | $175.68 |
52-Week Low | $120.88 | $141.95 |
Typical Hold Time | 12 Days | 100 Days |
Enterprise Value | $11.93B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MANH trades at $206.78, up 2.31% today, with a bullish technical outlook as it sits above key support at $205. The company shows strong profitability with a net margin of 18.67% and has beaten earnings estimates for three consecutive quarters. Recent news includes a product launch of Editions for its solutions but also ongoing legal investigations into fiduciary duties.
The outlook is cautiously optimistic given analyst consensus of Buy and a $210.50 price target, though high valuation ratios and legal overhangs present risks. Earnings growth remains the key catalyst for further upside, but investors should weigh the elevated P/E of 59.26 against potential legal and competitive pressures.
XLV trades at $168.16, down 0.39% with a bearish technical signal from moving averages. The healthcare ETF maintains strong cost advantages with a 0.08% expense ratio compared to peers. Recent news highlights XLV's defensive positioning during market volatility and its historical outperformance during Fed rate hikes. Technical indicators show RSI levels in neutral territory while ADX signals selling pressure.
XLV offers diversified healthcare exposure with competitive expense ratios, positioning it well for defensive investing. Key risks include political uncertainty around healthcare policy and concentrated exposure to domestic S&P 500 stocks. The ETF's low-cost structure and sector diversification provide stability amid market volatility, though technical indicators suggest near-term caution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Manhattan Associates Inc
Manhattan Associates, Inc. is a global leader in supply chain and omnichannel commerce software. The company provides a comprehensive suite of cloud-based and on-premise solutions for warehouse management (WMS), transportation management (TMS), and order management (OMS). MANH's technology helps retailers, wholesalers, and manufacturers manage inventory, optimize logistics, and unify the shopping experience across physical and digital channels.
Read more on MANH →About Health Care Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →
